Skip to main content
NIH funding notice PAR-19-044

End-of-Life and Palliative Care Approaches to Advanced Signs and Symptoms (R21- Clinical Trial Optional)

Closed on January 7, 2022.

Posted
October 31, 2018
Close date
January 7, 2022
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $465,730 in first-year total cost, median $232,865.

Most frequent study sections

  1. Biomaterials and Biointerfaces Study Section[BMBI]1
  2. Clinical Management of Patients in Community-based Settings Study Section[CMPC]1

Most frequent institutions

  1. RUSH UNIVERSITY MEDICAL CENTER1
  2. UNIVERSITY OF MASSACHUSETTS LOWELL1
Competing awards under PAR-19-044 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2022Novel reactive sorbents to sorb, immobilize, and transform malodorous molecules for palliative management of malignant fungating wounds1R21NR020177-01SUN, YUYUUNIVERSITY OF MASSACHUSETTS LOWELL, MA$230,230BMBI
2020The Use of a Digital Application for Reporting Pain and Pain Management in Home Hospice1R21NR018952-01A1MAYAHARA, MASAKORUSH UNIVERSITY MEDICAL CENTER, IL$235,500CMPC

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.